JP Morgan Chase
ZOM

JP Morgan Chase’s Zomedica Corp. ZOM Stock Holding History

JP Morgan Chase’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,410
Closed -$2.93K – 7899
2024
Q4 		$2.93K Buy
24,410
+23,497
+2,574% +$2.96K ﹤0.01% 6590
2024
Q3 		$125 Sell
913
-34
-4% -$5 ﹤0.01% 6971
2024
Q2 		$138 Buy
947
+34
+4% +$5 ﹤0.01% 6840
2024
Q1 		$133 Hold
913
– – ﹤0.01% 6864
2023
Q4 		$183 Sell
913
-579
-39% -$102 ﹤0.01% 7059
2023
Q3 		$250 Buy
1,492
+579
+63% +$112 ﹤0.01% 6813
2023
Q2 		$183 Hold
913
– – ﹤0.01% 6642
2023
Q1 		$0 Hold
913
– – ﹤0.01% 7556
2022
Q4 		$0 Hold
913
– – ﹤0.01% 7398
2022
Q3 		$0 Hold
913
– – ﹤0.01% 7190
2022
Q2 		$0 Sell
913
-4,116
-82% -$1.05K ﹤0.01% 7242
2022
Q1 		$1K Hold
5,029
– – ﹤0.01% 6528
2021
Q4 		$1K Buy
5,029
+913
+22% +$411 ﹤0.01% 6592
2021
Q3 		$2K Sell
4,116
-1,110,898
-100% -$656K ﹤0.01% 6364
2021
Q2 		$928K Buy
1,115,014
+851,982
+324% +$794K ﹤0.01% 4354
2021
Q1 		$416K Buy
+263,032
New +$430K ﹤0.01% 4795
2020
Q4 		– Sell
-285,800
Closed -$29K – 6186
2020
Q3 		$29K Buy
+285,800
New +$39.4K ﹤0.01% 5082
2020
Q1 		– Sell
-3,167
Closed -$1K – 5921
2019
Q4 		$1K Sell
3,167
-2,329
-42% -$783 ﹤0.01% 5574
2019
Q3 		$2K Sell
5,496
-380
-6% -$118 ﹤0.01% 5638
2019
Q2 		$1K Sell
5,876
-4,656
-44% -$1.41K ﹤0.01% 5724
2019
Q1 		$4K Sell
10,532
-4,821
-31% -$4.25K ﹤0.01% 5642
2018
Q4 		$19K Buy
15,353
+5,803
+61% +$9.2K ﹤0.01% 5343
2018
Q3 		$18K Sell
9,550
-732
-7% -$1.57K ﹤0.01% 5441
2018
Q2 		$23K Buy
+10,282
New +$20.6K ﹤0.01% 5280

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

JP Morgan Chase's ZOM Position: Q1 2025 in Review

JP Morgan Chase sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 24,410 shares — an estimated $2.93K sold.

JP Morgan Chase first reported a position in ZOM in Q2 2018 and held it in 24 quarters. The position peaked at $928K in Q2 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • JP Morgan Chase reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 24,410 Zomedica Corp. shares in Q1 2025, an estimated $2.93K.
  • JP Morgan Chase first reported a position in Zomedica Corp. in Q2 2018 and held it in 24 quarters.
  • JP Morgan Chase's Zomedica Corp. position peaked at $928K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.